Targeted radiotherapy boost helps paediatric ependymoma outcome

Children with ependymoma and residual disease after initial surgery and radiotherapy can benefit from further surgery and an extra boost of radiotherapy, according to new research. The findings, presented at the European Society for Radiotherapy and Oncology (ESTRO) 3rd Forum, show that higher and more targeted radiotherapy doses can make a difference in this particularly challenging patient population.